doi:10.3969/j.issn.1673-8640.2021.05.011

Abstract

CLC Number:

R446.1

Figures/Tables 4

References 21

[1]	ARABESTANI M R, RASTIANY S, KAZEMI S, et al. Conventional,molecular methods and biomarkers molecules in detection of septicemia[J]. Adv Biomed Res, 2015,4:120. DOI URL
[2]	FLEISCHMANN C, SCHERAG A, ADHIKARI N K, et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations[J]. Am J Respir Crit Care Med, 2016,193(3):259-272. DOI URL
[3]	PETERS R P H, VAN AGTMAEL M A, DANNER S A, et al. New developments in the diagnosis of bloodstream infections[J]. Lancet Infect Dis, 2004,4(12):751-760. DOI URL
[4]	THOMAS M R, STOREY R F. The role of platelets in inflammation[J]. Thromb Haemost, 2015,114(3):449-458. DOI URL
[5]	YEAMAN M R, BAYER A S, KOO S P, et al. Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action[J]. J Clin Invest, 1998,101(1):178-187. DOI URL
[6]	ALI R A, WUESCHER L M, DONA K R, et al. Platelets mediate host defense against Staphylococcus aureus through direct bactericidal activity and by enhancing macrophage activities[J]. J Immunol, 2017,198(1):344-351. DOI URL
[7]	BEARD M J, JEEWA Z, BASHIR S, et al. Comparison of platelet activation in platelet concentrates measured by flow cytometry or ADVIA 2120[J]. Vox Sang, 2011,101(2):122-130. DOI URL
[8]	CHO S Y, JEON Y L, KIM W, et al. Mean platelet volume and mean platelet volume/platelet count ratio in infective endocarditis[J]. Platelets, 2014,25(8):559-561. DOI URL
[9]	YARDIMCI S, UURLU M Ü, COKUN M, et al. Neutrophil-lymphocyte ratio and mean platelet volume can be a predictor for severity of acute appendicitis[J]. Ulus Travma Acil Cerrahi Derg, 2016,22(2):163-168.
[10]	LEE I R, SHIN J I, PARK S J, et al. Mean platelet volume in young children with urinary tract infection[J]. Sci Rep, 2015,5:18072. DOI URL
[11]	ATES S, OKSUZ H, DOGU B, et al. Can mean platelet volume and mean platelet volume/platelet count ratio be used as a diagnostic marker for sepsis and systemic inflammatory response syndrome?[J]. Saudi Med J, 2015,36(10):1186-1190. DOI URL
[12]	DE JAGER C P C, VAN WIJK P T L, MATHOERA R B, et al. Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit[J]. Crit Care, 2010,14(5):R192. DOI URL
[13]	FARAH R, IBRAHIM R, NASSAR M, et al. The neutrophil/lymphocyte ratio is a better addition to C-reactive protein than CD64 index as a marker for infection in COPD[J]. Panminerva Med, 2017,59(3):203-209.
[14]	HAUPTMAN N, GLAVA D. Colorectal cancer blood-based biomarkers[J]. Gastroenterol Res Pract, 2017,2017:2195361.
[15]	PYO J S, SOHN J H, KANG G. Diagnostic and prognostic roles of the mean platelet volume in malignant tumors:a systematic review and meta-analysis[J]. Platelets, 2016,27(8):722-728. DOI URL
[16]	黎赛, 李梨平, 宋春荣, 等. 平均血小板内容物浓度测定与血小板计数在脓毒症诊疗中的应用[J]. 中国感染控制杂志, 2010,9(1):25-27.
[17]	BLAIR P, FLAUMENHAFT R. Platelet alpha-granules:basic biology and clinical correlates[J]. Blood Rev, 2009,23(4):177-189. DOI URL
[18]	DEPPERMANN C, KUBES P. Start a fire,kill the bug:the role of platelets in inflammation and infection[J]. Innate Immun, 2018,24(6):335-348. DOI URL
[19]	徐瑞龙, 朱以军, 马拥军, 等. 败血症患者血小板相关参数的变化及意义[J]. 检验医学, 2008,23(3):314-316.
[20]	KITAZAWA T, YOSHINO Y, TATSUNO K, et al. Changes in the mean platelet volume levels after bloodstream infection have prognostic value[J]. Intern Med, 2013,52(13):1487-1493. DOI URL
[21]	GORELIK O, TZUR I, BARCHEL D, et al. A rise in mean platelet volume during hospitalization for community-acquired pneumonia predicts poor prognosis:a retrospective observational cohort study[J]. BMC Pulm Med, 2017,17(1):137. DOI URL

组别	例数	MPC/（mg/L）	MPV/fL	PLT计数/（×10⁹/L）	PLR	MPV/PLT比值/（fL×10^-5/μL）
感染组	89	243±20	9.6（8.6~10.6）	183±107	218（147~395）	5.7（3.8~9.2）
对照组	90	286±15	8.1（7.6~8.8）	212±58	114（91~147）	3.9（3.2~5.0）
统计值		-15.893	-7.064	-2.228	-6.410	-4.531
P值		<0.001	<0.001	0.028	<0.001	<0.001

组别	例数	MPC/（mg/L）	MPV/fL	PLT计数/（×10⁹/L）	PLR	MPV/PLT比值/（fL×10^-5/μL）
感染组	89	243±20	9.6（8.6~10.6）	183±107	218（147~395）	5.7（3.8~9.2）
对照组	90	286±15	8.1（7.6~8.8）	212±58	114（91~147）	3.9（3.2~5.0）
统计值		-15.893	-7.064	-2.228	-6.410	-4.531
P值		<0.001	<0.001	0.028	<0.001	<0.001

组别	例数	MPC/（mg/L）	MPV/fL	PLT计数/（×10⁹/L）	PLR	MPV/PLT比值/（fL×10^-5/μL）
G^-菌感染组	56	243.0±19.7	9.8（8.8~11.2）	162±99	210（101~380）	5.8（4.2~13.5）
G⁺菌感染组	33	240.4±22.4	9.7（8.1~10.2）	207±89	267（183~566）	4.7（3.1~8.8）
统计值		-0.542	-1.355	1.875	-2.056	-1.737
P值		0.589	0.175	0.065	0.040	0.820

组别	例数	MPC/（mg/L）	MPV/fL	PLT计数/（×10⁹/L）	PLR	MPV/PLT比值/（fL×10^-5/μL）
G^-菌感染组	56	243.0±19.7	9.8（8.8~11.2）	162±99	210（101~380）	5.8（4.2~13.5）
G⁺菌感染组	33	240.4±22.4	9.7（8.1~10.2）	207±89	267（183~566）	4.7（3.1~8.8）
统计值		-0.542	-1.355	1.875	-2.056	-1.737
P值		0.589	0.175	0.065	0.040	0.820

项目	AUC（95%可信区间）	最佳临界值	敏感性/%	特异性/%	阳性预测值/%	阴性预测值/%
MPC	0.954（0.913~0.980）	267 mg/L	93.3	88.9	89.3	94.1
MPV	0.806（0.740~0.861）	8.9 fL	68.5	81.2	80.4	71.6
PLR	0.777（0.709~0.836）	197	60.7	93.3	79.0	69.0
MPV/PLT比值	0.696（0.623~0.762）	5.3 fL×10^–5/μL	56.2	83.3	76.9	65.7
PLT计数	0.634（0.559~0.705）	182×10⁹/L	57.4	68.9	60.6	61.1

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 4

References 21

Related Articles 15

Recommended Articles

Metrics

[1]	FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114.
[2]	SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.
[3]	LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.
[4]	YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.
[5]	XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.
[6]	CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.
[7]	. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.
[8]	. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.
[9]	WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166.
[10]	YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.
[11]	DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.
[12]	GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.
[13]	. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.
[14]	. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.
[15]	. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.